Literature DB >> 15654338

Mutations in MRAP, encoding a new interacting partner of the ACTH receptor, cause familial glucocorticoid deficiency type 2.

Louise A Metherell1, J Paul Chapple, Sadani Cooray, Alessia David, Christian Becker, Franz Rüschendorf, Danielle Naville, Martine Begeot, Bernard Khoo, Peter Nürnberg, Angela Huebner, Michael E Cheetham, Adrian J L Clark.   

Abstract

Familial glucocorticoid deficiency (FGD), or hereditary unresponsiveness to adrenocorticotropin (ACTH; OMIM 202200), is an autosomal recessive disorder resulting from resistance to the action of ACTH on the adrenal cortex, which stimulates glucocorticoid production. Affected individuals are deficient in cortisol and, if untreated, are likely to succumb to hypoglycemia or overwhelming infection in infancy or childhood. Mutations of the ACTH receptor (melanocortin 2 receptor, MC2R) account for approximately 25% of cases of FGD. FGD without mutations of MC2R is called FGD type 2. Using SNP array genotyping, we mapped a locus involved in FGD type 2 to chromosome 21q22.1. We identified mutations in a gene encoding a 19-kDa single-transmembrane domain protein, now known as melanocortin 2 receptor accessory protein (MRAP). We show that MRAP interacts with MC2R and may have a role in the trafficking of MC2R from the endoplasmic reticulum to the cell surface.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15654338     DOI: 10.1038/ng1501

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  120 in total

1.  Regulation of G protein-coupled receptor signaling: specific dominant-negative effects of melanocortin 2 receptor accessory protein 2.

Authors:  Julien A Sebag; Patricia M Hinkle
Journal:  Sci Signal       Date:  2010-04-06       Impact factor: 8.192

Review 2.  Development and function of the human fetal adrenal cortex: a key component in the feto-placental unit.

Authors:  Hitoshi Ishimoto; Robert B Jaffe
Journal:  Endocr Rev       Date:  2010-11-04       Impact factor: 19.871

Review 3.  Endocrinology research-reflecting on the past decade and looking to the next.

Authors:  Kevan C Herold; Joseph A Majzoub; Shlomo Melmed; Merri Pendergrass; Martin Schlumberger
Journal:  Nat Rev Endocrinol       Date:  2015-10-13       Impact factor: 43.330

4.  Melanocortin-2 receptor accessory protein MRAP forms antiparallel homodimers.

Authors:  Julien A Sebag; Patricia M Hinkle
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-12       Impact factor: 11.205

Review 5.  The year in G protein-coupled receptor research.

Authors:  Robert P Millar; Claire L Newton
Journal:  Mol Endocrinol       Date:  2009-12-17

Review 6.  G protein-coupled receptors: mutations and endocrine diseases.

Authors:  Gilbert Vassart; Sabine Costagliola
Journal:  Nat Rev Endocrinol       Date:  2011-02-08       Impact factor: 43.330

7.  Melanocortin 2 receptor is required for adrenal gland development, steroidogenesis, and neonatal gluconeogenesis.

Authors:  Dai Chida; Shinichi Nakagawa; So Nagai; Hiroshi Sagara; Harumi Katsumata; Toshihiro Imaki; Harumi Suzuki; Fumiko Mitani; Tadashi Ogishima; Chikara Shimizu; Hayato Kotaki; Shigeru Kakuta; Katsuko Sudo; Takao Koike; Mitsumasa Kubo; Yoichiro Iwakura
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-07       Impact factor: 11.205

8.  Regions of melanocortin 2 (MC2) receptor accessory protein necessary for dual topology and MC2 receptor trafficking and signaling.

Authors:  Julien A Sebag; Patricia M Hinkle
Journal:  J Biol Chem       Date:  2008-11-03       Impact factor: 5.157

9.  Familial glucocorticoid deficiency with a point mutation in the ACTH receptor: a case report.

Authors:  Chan Jong Kim; Young Jong Woo; Gu Hwan Kim; Han Wook Yoo
Journal:  J Korean Med Sci       Date:  2009-09-23       Impact factor: 2.153

10.  Functional consequence of a novel Y129C mutation in a patient with two contradictory melanocortin-2-receptor mutations.

Authors:  Li F Chan; Teng-Teng Chung; Ahmed F Massoud; Louise A Metherell; Adrian J L Clark
Journal:  Eur J Endocrinol       Date:  2009-01-16       Impact factor: 6.664

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.